Literature DB >> 31446800

Long Noncoding RNA-DACH1 (Dachshund Homolog 1) Regulates Cardiac Function by Inhibiting SERCA2a (Sarcoplasmic Reticulum Calcium ATPase 2a).

Benzhi Cai1,2, Yang Zhang1, Yue Zhao1, Jin Wang1, Tingting Li1, Yiyuan Zhang1, Yuan Jiang1, Xuexin Jin1, Genlong Xue1, Penghui Li1, Yilin Sun1, Qihe Huang1, Xiaofang Zhang1, Wanzhen Su1, Ying Yang1, Yangyang Sun1, Ling Shi1, Xingda Li1, Yanjie Lu1, Baofeng Yang1, Zhenwei Pan1.   

Abstract

Heart failure (HF) is a major cause of morbidity and mortality in patients with various cardiovascular diseases. Restoration of cardiac function is critical in improving the clinical outcomes of patients with HF. Long noncoding RNAs are widely involved in the development of multiple cardiac diseases, whereas their role in regulating cardiac function remains unclear. In this study, we found that the expression of long noncoding RNA-DACH1 (dachshund homolog 1) was upregulated in the failing hearts of mice and human. We tested the hypothesis that the intronic long noncoding RNA of DACH1 (LncDACH1) can participate in the regulation of cardiac function and HF. Transgenic overexpression of LncDACH1 in the cardiac myocytes of mice led to impaired cardiac function, reduced calcium transient and cell shortening, and decreased SERCA2a (sarcoplasmic reticulum calcium ATPase 2a) protein expression. In contrast, conditional knockout of LncDACH1 in cardiac myocytes resulted in increased calcium transient, cell shortening, SERCA2a protein expression, and improved cardiac function of transverse aortic constriction induced HF mice. The same qualitative data were obtained by overexpression or knockdown of LncDACH1 with adenovirus carrying LncDACH1 or its siRNA. Moreover, therapeutic administration of adenovirus carrying LncDACH1 siRNA to transverse aortic constriction mice abolished the development of HF. Mechanistically, LncDACH1 directly binds to SERCA2a. Overexpression of LncDACH1 augments the ubiquitination of SERCA2a. LncDACH1 upregulation impairs cardiac function by promoting ubiquitination-related degradation of SERCA2a.

Entities:  

Keywords:  RNA, long noncoding; animals; heart failure; humans; ubiquitination

Mesh:

Substances:

Year:  2019        PMID: 31446800     DOI: 10.1161/HYPERTENSIONAHA.119.12998

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

Review 1.  Long non-coding RNAs: From disease code to drug role.

Authors:  Yuanyuan Chen; Zhaojun Li; Xiaoguang Chen; Sen Zhang
Journal:  Acta Pharm Sin B       Date:  2020-10-10       Impact factor: 11.413

2.  Cytoplasmic sequestration of p53 by lncRNA-CIRPILalleviates myocardial ischemia/reperfusion injury.

Authors:  Yuan Jiang; Ying Yang; Yang Zhang; Jiqin Yang; Man-Man Zhang; Shangxuan Li; Genlong Xue; Xingda Li; Xiaofang Zhang; Jiming Yang; Xiang Huang; Qihe Huang; Hongli Shan; Yanjie Lu; Baofeng Yang; Zhenwei Pan
Journal:  Commun Biol       Date:  2022-07-18

3.  Enhancement of LncRNA-HFRL expression induces cardiomyocyte inflammation, proliferation, and fibrosis via the sequestering of miR-149-5p-mediated collagen 22A inhibition.

Authors:  Xiaohua Li; Yun Teng; Miao Tian; Hailong Qiu; Junfei Zhao; Qiang Gao; Yong Zhang; Jian Zhuang; Jimei Chen
Journal:  Ann Transl Med       Date:  2022-05

4.  LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation.

Authors:  Jian Sun; Tongzhu Jin; Zhihui Niu; Jiayu Guo; Yingying Guo; Ruoxuan Yang; Qianqian Wang; Huiying Gao; Yuhan Zhang; Tianyu Li; Wenxin He; Zhixin Li; Wenchao Ma; Wei Su; Liangliang Li; Xingxing Fan; Hongli Shan; Haihai Liang
Journal:  Acta Pharm Sin B       Date:  2022-04-16       Impact factor: 14.903

Review 5.  Non-coding RNAs in cardiac regeneration: Mechanism of action and therapeutic potential.

Authors:  Yi Wang; Jinghai Chen; Douglas B Cowan; Da-Zhi Wang
Journal:  Semin Cell Dev Biol       Date:  2021-07-17       Impact factor: 7.499

Review 6.  Non-coding RNAs: emerging players in cardiomyocyte proliferation and cardiac regeneration.

Authors:  Naisam Abbas; Filippo Perbellini; Thomas Thum
Journal:  Basic Res Cardiol       Date:  2020-08-03       Impact factor: 17.165

Review 7.  Reverse-genetics studies of lncRNAs-what we have learnt and paths forward.

Authors:  Fan Gao; Ye Cai; Philipp Kapranov; Dongyang Xu
Journal:  Genome Biol       Date:  2020-04-14       Impact factor: 13.583

8.  GAS5 protects against osteoporosis by targeting UPF1/SMAD7 axis in osteoblast differentiation.

Authors:  Ming Li; Zhongyu Xie; Jinteng Li; Jiajie Lin; Guan Zheng; Wenjie Liu; Su'an Tang; Shuizhong Cen; Guiwen Ye; Zhaofeng Li; Wenhui Yu; Peng Wang; Yanfeng Wu; Huiyong Shen
Journal:  Elife       Date:  2020-10-02       Impact factor: 8.140

Review 9.  LncRNAs in cardiac hypertrophy: From basic science to clinical application.

Authors:  Lei Liu; Donghui Zhang; Yifei Li
Journal:  J Cell Mol Med       Date:  2020-09-08       Impact factor: 5.310

10.  Sarcolipin Exhibits Abundant RNA Transcription and Minimal Protein Expression in Horse Gluteal Muscle.

Authors:  Joseph M Autry; Christine B Karim; Sudeep Perumbakkam; Carrie J Finno; Erica C McKenzie; David D Thomas; Stephanie J Valberg
Journal:  Vet Sci       Date:  2020-11-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.